Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer

Targeted anti-vascular therapies for ovarian cancer: current evidence

(2013) M Hall et al.   BRITISH JOURNAL OF CANCER

Oral adjuvant clodronate therapy could improve overall survival in early breast cancer: Results from an updated systematic review and meta-analysis

(2013) Jianhong Zhu et al.   EUROPEAN JOURNAL OF CANCER

Reciprocal interactions between endothelial cells and macrophages in angiogenic vascular niches

(2013) Caroline Baer et al.   EXPERIMENTAL CELL RESEARCH

Biomedical applications of bisphosphonates

(2013) Elisabeth V. Giger et al.   JOURNAL OF CONTROLLED RELEASE

Bisphosphonates in the Adjuvant Treatment of Breast Cancer

(2012) M.C. Winter et al.   CLINICAL ONCOLOGY

Macrophages, Inflammation, and Tumor Suppressors: ARF, a New Player in the Game

(2012) Paqui G. Través et al.   MEDIATORS OF INFLAMMATION

Adjuvant Effect of IV Clodronate on the Delay of Bone Metastasis in High-Risk Prostate Cancer Patients: A Prospective Study

(2012) Paulo Rodrigues et al.   Cancer Research and Treatment

Bisphosphonates: The first 40years

(2011) R. Graham G. Russell   BONE

TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice

(2011) Abigail F. Welford et al.   JOURNAL OF CLINICAL INVESTIGATION

Molecular mechanisms and clinical applications of angiogenesis

(2011) Peter Carmeliet et al.   NATURE

Bisphosphonates significantly increase the activity of doxorubicin or vincristine against canine malignant histiocytosis cells

(2011) S. D. Hafeman et al.   Veterinary and Comparative Oncology

Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy

(2011) David G. DeNardo et al.   Cancer Discovery

Management of castration-resistant prostate cancer: bisphosphonates and emerging therapies

(2010) Fred Saad et al.   Expert Review of Anticancer Therapy

First-line treatment of advanced ovarian cancer: current research and perspectives

(2009) Claudia Marchetti et al.   Expert Review of Anticancer Therapy